Supply Chain/Logistics

COVID-19: Shoring Up the Drug Delivery Infrastructure

July 01, 2020

Manufacturers and the US government are investing heavily in traditional and non-traditional forms and materials to ensure supplies of containers and delivery devices for COVID-19 treatments and vaccines.

Corning Expands Glass Vial Capacity

June 17, 2020

Corning will use BARDA funding to expand US manufacturing capacity for pharmaceutical tubing and vials made from Valor glass.

SiO2 Scales Up Container Technology for COVID-19 Vaccines and Treatments

June 08, 2020

SiO2 Materials Science has received $143 million from the US government to accelerate capacity scale-up of its advanced primary packaging platform.

Cryogenic Capsule for Shipment of Cellular Therapies

June 04, 2020

The VIA Capsule from Cytiva is a liquid nitrogen-free cryogenic shipment system designed to transport cell therapies.

Finding New Efficiencies in Clinical Trial Logistics

June 01, 2020

The COVID-19 pandemic has led to increased demand for direct-to-patient shipments, challenging cold-chain specialists to become more agile and to strengthen their global distribution networks.

2019 Investments Centered around Cell and Gene Therapies

June 01, 2020

Previous investments set a foundation for later efficiency improvements.

What’s Next in Air Transportation

June 01, 2020

The future will bring changes for temperature-controlled container rental companies.

The US Government Moves Forward with Plans for Accelerating Manufacturing of COVID-19 Vaccines and Treatments

May 18, 2020

Leadership was announced for the US government’s Operation Warp Speed program, which aims to deliver COVID-19 vaccines, therapeutics, and diagnostics.

Packaging Preserves the Cold Chain

April 01, 2020

More sustainable and functional packaging protects temperature-sensitive drugs.

Manufacturing APIs and the Supply Chain

April 01, 2020

Pharmaceutical Technology spoke with Jens Andersson, purchasing director at Cambrex Karlskoga, about the best way to ensure the security of the bio/pharmaceutical materials supply chain.